Trial Profile
Phase II trial of polifeprosan 20 with carmustine implant, Interferon-beta and Temozolomide Combination Chemoradiotherapy for Newly Diagnosed Glioblastomas
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Carmustine polifeprosan 20 wafer (Primary) ; Interferon beta; Temozolomide
- Indications Glioblastoma
- Focus Therapeutic Use
- 23 Apr 2013 New trial record